224 related articles for article (PubMed ID: 31385869)
1. Preeclamptic patient-derived circulating cell-free DNA activates the production of inflammatory cytokines via toll-like receptor 9 signalling in the human placenta.
Ozeki A; Tani K; Takahashi H; Suzuki H; Nagayama S; Hirashima C; Iwata H; Kuwayama T; Ohkuchi A; Shirasuna K
J Hypertens; 2019 Dec; 37(12):2452-2460. PubMed ID: 31385869
[TBL] [Abstract][Full Text] [Related]
2. Cell-free fetal DNA impairs trophoblast migration in a TLR9-dependent manner and can be reversed by hydroxychloroquine.
León-Martínez D; Lynn T; Abrahams VM
J Reprod Immunol; 2023 Jun; 157():103945. PubMed ID: 37062109
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor 9, maternal cell-free DNA and myometrial cell response to CpG oligodeoxynucleotide stimulation.
Beck S; Buhimschi IA; Summerfield TL; Ackerman WE; Guzeloglu-Kayisli O; Kayisli UA; Zhao G; Schatz F; Lockwood CJ; Buhimschi CS
Am J Reprod Immunol; 2019 Apr; 81(4):e13100. PubMed ID: 30758898
[TBL] [Abstract][Full Text] [Related]
4. Elevated cell-free fetal DNA contributes to placental inflammation and antiangiogenesis via AIM2 and IFI16 during pre-eclampsia.
Li N; He F; Gao H; Ge Y; Fan X; Zhang J; Qi H; Ren L
J Cell Physiol; 2020 Dec; 235(12):9577-9588. PubMed ID: 32383175
[TBL] [Abstract][Full Text] [Related]
5. Cell-Free Foetal DNA as a Useful Marker for Preeclampsia Prediction.
Karapetian АО; Baev ОR; Sadekova АА; Krasnyi АМ; Sukhikh GT
Reprod Sci; 2021 May; 28(5):1563-1569. PubMed ID: 33475978
[TBL] [Abstract][Full Text] [Related]
6. The Influence of Maternal Obesity on Cell-Free Fetal DNA and Blood Pressure Regulation in Pregnancies with Hypertensive Disorders.
Stupak A; Kwaśniewski W; Goździcka-Józefiak A; Kwaśniewska A
Medicina (Kaunas); 2021 Sep; 57(9):. PubMed ID: 34577885
[No Abstract] [Full Text] [Related]
7. Cell-free nucleic acids in (maternal) blood: any relevance to (reproductive) immunologists?
Hahn S; Giaglis S; Buser A; Hoesli I; Lapaire O; Hasler P
J Reprod Immunol; 2014 Oct; 104-105():26-31. PubMed ID: 24815811
[TBL] [Abstract][Full Text] [Related]
8. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
Holme AM; Roland MC; Henriksen T; Michelsen TM
Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
[TBL] [Abstract][Full Text] [Related]
9. Elevated S100A9 in preeclampsia induces soluble endoglin and IL-1β secretion and hypertension via the NLRP3 inflammasome.
Ozeki A; Oogaki Y; Henmi Y; Karasawa T; Takahashi M; Takahashi H; Ohkuchi A; Shirasuna K
J Hypertens; 2022 Jan; 40(1):84-93. PubMed ID: 34412079
[TBL] [Abstract][Full Text] [Related]
10. Association of pro- and anti-inflammatory cytokines in preeclampsia.
Aggarwal R; Jain AK; Mittal P; Kohli M; Jawanjal P; Rath G
J Clin Lab Anal; 2019 May; 33(4):e22834. PubMed ID: 30666720
[TBL] [Abstract][Full Text] [Related]
11. TLR9 (Toll-Like Receptor 9) Agonist Suppresses Angiogenesis by Differentially Regulating VEGFA (Vascular Endothelial Growth Factor A) and sFLT1 (Soluble Vascular Endothelial Growth Factor Receptor 1) in Preeclampsia.
He B; Yang X; Li Y; Huang D; Xu X; Yang W; Dai Y; Zhang H; Chen Z; Cheng W
Hypertension; 2018 Apr; 71(4):671-680. PubMed ID: 29437897
[TBL] [Abstract][Full Text] [Related]
12. [Expression and significance of SATB1 and wnt/β-catenin signaling molecule in the placenta of preeclampsia].
Zhuang B; Luo X; Rao H; Li Q; Liu X; Qi H
Zhonghua Fu Chan Ke Za Zhi; 2015 Apr; 50(4):283-90. PubMed ID: 26080941
[TBL] [Abstract][Full Text] [Related]
13. At Preeclampsia Diagnosis, Total Cell-Free DNA Concentration is Elevated and Correlates With Disease Severity.
Kolarova TR; Gammill HS; Nelson JL; Lockwood CM; Shree R
J Am Heart Assoc; 2021 Aug; 10(15):e021477. PubMed ID: 34310191
[TBL] [Abstract][Full Text] [Related]
14. Inflammation-mediated generation and inflammatory potential of human placental cell-free fetal DNA.
van Boeckel SR; Macpherson H; Norman JE; Davidson DJ; Stock SJ
Placenta; 2020 Apr; 93():49-55. PubMed ID: 32250739
[TBL] [Abstract][Full Text] [Related]
15. Expression of inflammatory cytokines in placentas from women with preeclampsia.
Benyo DF; Smarason A; Redman CW; Sims C; Conrad KP
J Clin Endocrinol Metab; 2001 Jun; 86(6):2505-12. PubMed ID: 11397847
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D and Inflammatory Cytokines in Healthy and Preeclamptic Pregnancies.
Barrera D; Díaz L; Noyola-Martínez N; Halhali A
Nutrients; 2015 Aug; 7(8):6465-90. PubMed ID: 26247971
[TBL] [Abstract][Full Text] [Related]
17. Fetal and Placental DNA Stimulation of TLR9: A Mechanism Possibly Contributing to the Pro-inflammatory Events During Parturition.
Goldfarb IT; Adeli S; Berk T; Phillippe M
Reprod Sci; 2018 May; 25(5):788-796. PubMed ID: 28884630
[TBL] [Abstract][Full Text] [Related]
18. Maternal total cell-free DNA in preeclampsia and fetal growth restriction: Evidence of differences in maternal response to abnormal implantation.
Rafaeli-Yehudai T; Imterat M; Douvdevani A; Tirosh D; Benshalom-Tirosh N; Mastrolia SA; Beer-Weisel R; Klaitman V; Riff R; Greenbaum S; Alioshin A; Rodavsky Hanegbi G; Loverro G; Catalano MR; Erez O
PLoS One; 2018; 13(7):e0200360. PubMed ID: 30001403
[TBL] [Abstract][Full Text] [Related]
19. Inhibiting trophoblast PAR-1 overexpression suppresses sFlt-1-induced anti-angiogenesis and abnormal vascular remodeling: a possible therapeutic approach for preeclampsia.
Zhao Y; Zheng Y; Liu X; Luo Q; Wu D; Liu X; Zou L
Mol Hum Reprod; 2018 Mar; 24(3):158-169. PubMed ID: 29325127
[TBL] [Abstract][Full Text] [Related]
20. Trophoblast debris extruded from preeclamptic placentae activates endothelial cells: a mechanism by which the placenta communicates with the maternal endothelium.
Shen F; Wei J; Snowise S; DeSousa J; Stone P; Viall C; Chen Q; Chamley L
Placenta; 2014 Oct; 35(10):839-47. PubMed ID: 25096950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
